Amphastar Pharmaceuticals (AMPH) Current Leases (2019 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Current Leases of $9.7 million for Q1 2026, up 25.29% year-over-year from $7.7 million in Q1 2025, and up 22.41% quarter-over-quarter from $7.9 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Current Leases (2019 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $9.7 million for Q1 2026.
- In Q1 2026, Current Leases rose 25.29% year-over-year to $9.7 million; the TTM figure through Mar 2026 stood at $9.7 million (up 25.29% YoY), while the FY2025 annual figure was $7.9 million, up 16.52% from the prior year.
- Current Leases for Q1 2026 stood at $9.7 million, up from $7.9 million in the prior quarter.
- The five-year high for Current Leases was $9.7 million in Q1 2026, with the low at $3.0 million in Q1 2023.
- The 5-year median for Current Leases is $3.9 million (2024), against an average of $5.1 million.
- The sharpest annual moves came in 2022 and 2025: Current Leases declined 11.43% in 2022, then soared 97.17% in 2025.
- Amphastar Pharmaceuticals' Current Leases stood at $3.0 million in 2022, then surged by 30.07% to $3.9 million in 2023, then jumped by 74.19% to $6.8 million in 2024, then advanced by 16.52% to $7.9 million in 2025, then increased by 22.41% to $9.7 million in 2026.
- Business Quant data shows AMPH's Current Leases at $9.7 million in Q1 2026, $7.9 million in Q4 2025, and $7.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn | 8.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.80 Mn |
| Mar 31, 2026 | 9.71 Mn |
| Dec 31, 2025 | 7.93 Mn |
| Sep 30, 2025 | 7.83 Mn |
| Jun 30, 2025 | 7.88 Mn |
| Mar 31, 2025 | 7.75 Mn |
| Dec 31, 2024 | 6.80 Mn |
| Sep 30, 2024 | 4.21 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 3.94 Mn |
| Dec 31, 2023 | 3.91 Mn |
| Sep 30, 2023 | 3.72 Mn |
| Jun 30, 2023 | 3.13 Mn |
| Mar 31, 2023 | 2.99 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 3.18 Mn |
| Jun 30, 2022 | 3.32 Mn |
| Mar 31, 2022 | 3.28 Mn |
| Dec 31, 2021 | 2.98 Mn |
| Sep 30, 2021 | 2.86 Mn |